Emma L. Ledger
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment of Pseudomonas by Removal of Cloaking Antibodies: Is Common Polysaccharide Antigen a Factor?
Journal: The Journal of infectious diseases
Published: October 12, 2025
Emerging antimicrobial therapies for Gram-negative infections in human clinical use.
Journal: npj antimicrobials and resistance
Published: November 04, 2024
Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing.
Journal: Frontiers in cellular and infection microbiology
Published: May 02, 2024
Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis.
Journal: The Journal of infectious diseases
Published: November 22, 2023
Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.
Journal: Infection and immunity
Published: August 30, 2021
Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: November 26, 2020
Genetic, Morphological and Antigenic Relationships between Mesonivirus Isolates from Australian Mosquitoes and Evidence for Their Horizontal Transmission.
Journal: Viruses
Published: September 04, 2020
Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies.
Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: June 06, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026